Deng et al. found that hsa-miR-342-5p may act as a tumor suppressor in osteosarcoma (OS) by targeting Wnt7b to inhibit the effects on OS cells viability, migration, invasion, sensitivity to Doxorubicin and apoptosis [81]. Here, WNT7B is linked to neoplasm.